skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Tetanus Peptide Melanoma Vaccine (Code C2468)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Tetanus Peptide Melanoma Vaccine

Definition: A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth. (NCI04)

Display Name: Tetanus Peptide Melanoma Vaccine

Label: Tetanus Peptide Melanoma Vaccine

NCI Thesaurus Code: C2468 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0677989  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Tetanus Peptide Melanoma Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 42978
PDQ Open Trial Search ID 42978 (check for NCI PDQ open clinical trial info)
UMLS CUI C0677989

Other Properties:
     Name Value (qualifiers indented underneath)
code C2468
Contributing_Source CTRP
Legacy_Concept_Name Tetanus_Peptide_Melanoma_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom